Literature DB >> 26590664

Prevalence of multiple sclerosis in Brazil: A systematic review.

Ana Beatriz Calmon Nogueira da Gama Pereira1, Maria Clinete Sampaio Lacativa2, Fernanda Ferreira Chaves da Costa Pereira3, Regina Maria Papais Alvarenga4.   

Abstract

Epidemiological studies of multiple sclerosis (MS) conducted in Latin America have revealed prevalence rates of this disease from low to medium. The aim of this study was to gather and analyze surveys on prevalence conducted in Brazil, noting its variability in different regions. Systematic review was held in electronic databases and manual search in abstracts concerning ECTRIMS, LACTRIMS and Brazilian Congress of Neurology. Nineteen studies made reference to prevalence rates that ranged from 1.36/100,000 to 27.2/100.000 inhabitants. More studies on the epidemiology of MS in Brazil will be needed for a better assessment of its prevalence and profile.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brazil; Epidemiology; Incidence; Multiple Sclerosis; Prevalence

Mesh：

Year:  2015        PMID： 26590664     DOI： 10.1016/j.msard.2015.08.004

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN： 2211-0348            Impact factor:   4.339


  6 in total

1.  Multiple sclerosis epidemiology in Latin America: An updated survey.

Authors:  Edgardo Cristiano; Juan Ignacio Rojas
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-06-13

2.  The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.

Authors:  Isabela Maia Diniz; Augusto Afonso Guerra; Livia Lovato Pires de Lemos; Kathiaja M Souza; Brian Godman; Marion Bennie; Björn Wettermark; Francisco de Assis Acurcio; Juliana Alvares; Eli Iola Gurgel Andrade; Mariangela Leal Cherchiglia; Vânia Eloisa de Araújo
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

3.  Burden and cost of multiple sclerosis in Brazil.

Authors:  Gisela Kobelt; Vanessa Teich; Marcela Cavalcanti; Ana Maria Canzonieri
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

4.  Physical and functional aspects of persons with multiple sclerosis practicing Tai-Geiko: randomized trial.

Authors:  Viviane Regina Leite Moreno Ultramari; Adriano Percival Calderaro Calvo; Rosilene Andrade Silva Rodrigues; Waléria Christiane Rezende Fett; Jose Urias de Moraes Neto; Almir de França Ferraz; Michelle Jalousie Kommers; Heloise Helena Siqueira Borges; Michell Vetoraci Viana; Monica Cattafesta; Luciane Bresciani Salaroli; Carlos Alexandre Fett
Journal:  Clinics (Sao Paulo)       Date:  2020-01-10       Impact factor: 2.365

Review 5.  The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.

Authors:  Livia Lovato Pires de Lemos; Augusto Afonso Guerra Júnior; Marisa Santos; Carlos Magliano; Isabela Diniz; Kathiaja Souza; Ramon Gonçalves Pereira; Juliana Alvares; Brian Godman; Marion Bennie; Ivan Ricardo Zimmermann; Vânia Crisitna Canuto Dos Santos; Clarice Alegre Pretramale; Francisco de Assis Acurcio
Journal:  Pharmacoeconomics       Date:  2018-02       Impact factor: 4.981

6.  Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.

Authors:  Guilherme Silva Julian; Ricardo Papaléo Rosim; Estela Cristina Carneseca; Jéssica Rigolon
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.